Nitroglycerin tolerance in caveolin-1 deficient mice.

Area of Science:

• Cardiovascular Biology
• Molecular Pharmacology
• Endothelial Function

Background:

• Nitroglycerin (GTN) therapy is limited by nitrate tolerance.
• GTN's vasodilatory effects depend on endothelial nitric oxide synthase (eNOS/NOS3).
• Caveolin-1 (Cav-1) interacts with NOS3, inhibiting its activity within caveolae.

Purpose of the Study:

• To investigate the hypothesis that nitrate tolerance results from NOS3 dysfunction and vascular toxicity induced by persistent GTN treatment.
• To elucidate the role of Cav-1 in GTN-induced nitrate tolerance.

Main Methods:

• Exposure of cultured endothelial cells and Cav-1 deficient mice to GTN for 48-72 hours.
• Assessment of Cav-1 nitrosation and depletion.
• Measurement of NOS3 uncoupling via peroxynitrite production.
• Evaluation of endothelial toxicity and vasodilation response.

Main Results:

• Persistent GTN exposure led to Cav-1 nitrosation and depletion (>50%).
• NOS3 uncoupling increased significantly (>100% peroxynitrite production) with concurrent endothelial toxicity.
• Cav-1 deficient mice exhibited NOS3 dysfunction and significant GTN tolerance.

Conclusions:

• Nitrate tolerance is caused by GTN-induced Cav-1 modification and depletion.
• This process leads to persistent NOS3 activation and uncoupling.
• The dysfunctional NOS3 cannot participate in GTN-mediated vasodilation, explaining tolerance.